Insights from a global oncology network
Sharing and analyzing real-world data to generate quality insights that improve outcomes for all people with cancer.
The complexity of precision medicine requires insights from the real world
Syapse offerings for health systems enable:
High-level oversight of the practice of precision medicine at your health system
Optimization of your clinical trial portfolio for your real-world oncology patient population
The application of molecular diagnostics data to clinical care decisions
-
Syapse Executive
Monitor and optimize the performance of your precision medicine programs through a consultative approach to managing interactive dashboards.
-
Syapse Insights
The power of real-world data: expand trial enrollment, enable development of exciting new hypotheses, and apply real-world outcomes knowledge to clinical care.
-
Syapse Oncology
Search molecular results for quick interpretation and action; optimize molecular tumor boards; identify candidates for targeted therapies or genetic counseling with fully integrated clinical and molecular data.
Connectivity with clinical databases, systems, and sources
Precision medicine requires centralized access to patient data that are typically siloed in electronic health records (EHRs), data warehouses, registries, and other systems. Syapse integrates patients’ clinical, pathology, radiology, treatment, lab results, and other information in a central data store to provide a single point of access.
Direct integration with molecular labs to capture structured molecular data
Today, genomic and other molecular test results are typically scanned into EHR systems and stored as unstructured data. Through direct integration with molecular diagnostics labs, Syapse enables healthcare systems to capture molecular profiles as structured data that can be used for decision support in the clinical workflow.
Common data standards across the network
Syapse standardizes and normalizes a robust set of data from multiple systems, allowing health systems to share data with other institutions, including patient demographics, cancer diagnoses, tumor genomics, tumor markers, treatments, and outcomes.
Resources
-
Syapse Overview Brochure
-
Syapse Offerings for Health Systems
What's new
Syapse Looks to Dive Deeper Into Large Health Systems for Data-Driven Cancer Insights
Fresh off a $68 million funding round, Syapse is moving quickly to expand its network of partnerships with life sciences companies, health systems, molecular laboratories, and regulators. “We’re right in the middle of growth mode right now,” CEO Ken Tarkoff said of the 13-year-old company. The San Francisco-based maker of software to support precision oncology care and drug discovery also raised $30 million in a round that closed in May 2020.
ReadBlog
A Real World Dialogue with Dr. Leroy Hood of Institute of Systems Biology
Inaugural Real World Dialogue kicked off with industry heavyweight Dr. Leroy (Lee) Hood sharing his perspective on how real-world evidence will evolve over the years and its potential to end suffering from cancer and other health challenges.
Read